Voyageur Pharmaceuticals Ltd. (TSXV:VM)
Canada · Delayed Price · Currency is CAD 0.1600
-0.0100 (-5.88%)
Sep 18, 2026, 3:56 PM EST
Voyageur Pharmaceuticals Market Cap
Voyageur Pharmaceuticals has a market cap or net worth of CAD 36.21 million as of September 18, 2026. Its market cap has increased by 30.99% in one year.
Market Cap
36.21M
Enterprise Value
35.81M
Revenue
47.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
ChartMarket Cap Chart
Since March 10, 2017, Voyageur Pharmaceuticals's market cap has increased from 4.76M to 36.21M, an increase of 660.66%. That is a compound annual growth rate of 23.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 36.21M | 19.29% |
| Dec 31, 2025 | 30.36M | 130.87% |
| Dec 31, 2024 | 13.15M | 32.12% |
| Dec 29, 2023 | 9.95M | -0.88% |
| Dec 30, 2022 | 10.04M | 9.57% |
| Dec 31, 2021 | 9.16M | 57.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vext Science | 61.93M |
| BioNxt Solutions | 55.12M |
| ZYUS Life Sciences | 48.31M |
| LSL Pharma Group | 39.92M |
| Optimi Health | 39.68M |
| 1CM Inc. | 35.32M |
| iAnthus Capital Holdings | 34.87M |
| Rubicon Organics | 30.75M |